According to Precision Business Insights (PBI) latest report, the global poultry vaccine market is valued at USD 2199.8 million in 2021. The global poultry vaccine market segmented into following types: By Vaccine (Inactivated Vaccines, Live Attenuated Vaccines, and Others), By Application (Marek’s Disease, Newcastle Disease, Infectious Bursal Disease, Infectious Bronchitis, Avian Influenza, Coccidiosis, Mycoplasma, and Others), and Geography (North America, Europe, Asia-Pacific, Latin America, and Middle East Africa) Forecast to 2028. Key player’s profiles in the poultry vaccine market report are Merck & Co., Inc., Elanco, Boehringer Ingelheim International GmbH, Biovac., Zoetis, Hester Biosciences Limited, KM Biologics, and Phibro Animal Health Corporation. The disease outbreaks in poultry drive the poultry vaccine market. The disease outbreaks in poultry drive the poultry vaccine market. Moreover, because contaminated meat poses a health risk to humans, it is critical that the birds be vaccinated before use. The main challenges that chicken farms confront are illness spread and a lack of treatment alternatives. Vaccination becomes mandatory to avoid such occurrences. Increased demand for poultry production and disease outbreaks in poultry are the key factors boosting the growth of the poultry vaccine market. Increased population, increased purchasing power, and urbanization has been significant growth drivers. Furthermore, growing consumption of meat globally, initiatives are taken by the government, and increasing demand for poultry-related food products are the major factors driving the market’s growth. The increasing cost of the vaccine, increasing acceptance of vegetarian food, and decreasing the production of advanced vaccines are the factors that are hindering the global market.
View Detailed Report Description at https://precisionbusinessinsights.com/market-reports/poultry-vaccines-market/
Attenuated Live Vaccines Segment Dominates the Poultry Vaccine Market
The attenuated live vaccines sector generated the most revenue in 2021. The growth of this segment is being driven by live attenuated vaccines, which produce a robust, strong antibody and cell-mediated immune response, long-lasting immunity, and a relatively quick onset of action. Moreover, attenuated live vaccines are an excellent simulation for the immune system. So live attenuated vaccines can result in lifelong immunity with just one or two doses.
North America Leads Poultry Vaccine Market
Due to increased demand for poultry food, nutritious chicken food, and government requirements for the safety of poultry birds, North America poultry vaccine is expected to have a large market share in the global market in the next years. In addition, due to the presence of prominent players, increased measures against the use of antimicrobials in animals, and rising worries about zoonoses, Europe accounted for a large revenue share in the global poultry vaccine market over the anticipated years.
Strategic New Product Launches, Mergers, Acquisitions and Agreements are the key strategies adopted by market players
Global poultry vaccine market further reveals that the key players increasingly adopting strategies such as launch of newer products, product launches, and long-term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance, In August 2021, Elanco Animal Health Incorporated announced it has closed the acquisition of Bayer Animal Health. The transaction, valued at $6.89 billion, expands Elanco’s scale and capabilities, positioning the company for the long term as a leader in the attractive, durable animal health industry. In November 2021, Hester Biosciences announced it has entered a pact to acquire 50 per cent stake in Tanzania-based animal health products distribution firm Thrishool Exim Ltd, for USD 2.25 million (around Rs 16 crore)
Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=20941
The poultry vaccine market detailed segmentation
Based on the Vaccine, the market is segmented into the following:
- Inactivated Vaccines
- Live Attenuated Vaccines
Based on the Application, the market is segmented into the following:
- Marek’s Disease
- Newcastle Disease
- Infectious Bursal Disease
- Infectious Bronchitis
- Avian Influenza
Based on the Regional Reports, the market is segmented into the following:
- North America Poultry Vaccines Market
- Europe Poultry Vaccines Market
- Asia Pacific Poultry Vaccines Market
- Latin America Poultry Vaccines Market
- MEA Poultry Vaccines Market
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747